Costs of Inpatient Care Among Medicare Beneficiaries With Heart Failure, 2001 to 2004

被引:57
作者
Whellan, David J. [1 ,3 ]
Greiner, Melissa A. [4 ]
Schulman, Kevin A. [2 ,4 ]
Curtis, Lesley H. [2 ,4 ]
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Div Cardiol, Philadelphia, PA 19017 USA
[2] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA
[3] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA
[4] Duke Univ, Sch Med, Ctr Clin & Genet Econ, Durham, NC USA
关键词
health care costs; heart failure; hospitalization; Medicare; CONVERTING-ENZYME-INHIBITOR; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR EVENTS; DIABETES-MELLITUS; OUTCOMES RESEARCH; MORTALITY; TRIAL; MORBIDITY; RAMIPRIL; PERINDOPRIL;
D O I
10.1161/CIRCOUTCOMES.109.854760
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Inpatient care is the primary driver of costs for patients with heart failure. It is unclear whether recent advances in heart failure care have reduced the costs to Medicare for the care of inpatients with heart failure. Methods and Results-In a retrospective cohort study of 1 363 977 elderly Medicare beneficiaries hospitalized with heart failure between January 1, 2001, and December 31, 2004, we examined costs to Medicare for all inpatient care, inpatient cardiovascular care, and inpatient heart failure care and the adjusted relationships between patient characteristics and costs. Among 1 363 977 Medicare beneficiaries with an index heart failure hospitalization, 901 885 (66%) had a subsequent inpatient claim during the following year. Noncardiovascular costs accounted for 57% of total inpatient costs, and costs associated with heart failure hospitalizations accounted for 15% of total inpatient costs. No significant changes occurred in total, cardiovascular, and heart failure inpatient costs over time. Conclusions-The costs of inpatient care for patients with heart failure are high, but most subsequent inpatient costs are attributable to noncardiovascular and non-heart failure admissions. Further research is needed to identify predictors of costs, so that patients can be stratified according to risk, and to evaluate strategies that target primary cost drivers for patients with heart failure. (Circ Cardiovasc Qual Outcomes. 2010; 3: 33-40.)
引用
收藏
页码:33 / 40
页数:8
相关论文
共 31 条
[1]   Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis - A randomized controlled trial [J].
Agodoa, LY ;
Appel, L ;
Bakris, GL ;
Beck, G ;
Bourgoignie, J ;
Briggs, JP ;
Charleston, J ;
Cheek, D ;
Cleveland, W ;
Douglas, JG ;
Douglas, M ;
Dowie, D ;
Faulkner, M ;
Gabriel, A ;
Gassman, J ;
Greene, T ;
Hall, Y ;
Hebert, L ;
Hiremath, L ;
Jamerson, K ;
Johnson, CJ ;
Kopple, J ;
Kusek, J ;
Lash, J ;
Lea, J ;
Lewis, JB ;
Lipkowitz, M ;
Massry, S ;
Middleton, J ;
Miller, ER ;
Norris, K ;
O'Connor, D ;
Ojo, A ;
Phillips, RA ;
Pogue, V ;
Rahman, M ;
Randall, OS ;
Rostand, S ;
Schulman, G ;
Smith, W ;
Thornley-Brown, D ;
Tisher, CC ;
Toto, RD ;
Wright, JT ;
Xu, SC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (21) :2719-2728
[2]   Prevalence and prognostic significance of heart failure stages - Application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community [J].
Ammar, Khawaja Afzal ;
Jacobsen, Steven J. ;
Mahoney, Douglas W. ;
Kors, Jan A. ;
Redfield, Margaret M. ;
Burnett, John C., Jr. ;
Rodeheffer, Richard J. .
CIRCULATION, 2007, 115 (12) :1563-1570
[3]  
[Anonymous], 2000, LANCET
[4]  
Arday SL, 2000, HEALTH CARE FINANC R, V21, P107
[5]   Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors [J].
Birman-Deych, E ;
Waterman, AD ;
Yan, Y ;
Nilasena, DS ;
Radford, MJ ;
Gage, BF .
MEDICAL CARE, 2005, 43 (05) :480-485
[6]   Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study [J].
Briggs, Andrew ;
Mihaylova, Borislava ;
Sculpher, Mark ;
Hall, Alistair ;
Wolstenholme, Jane ;
Simoons, Maarten ;
Deckers, Jaap ;
Ferrari, Roberto ;
Remme, Willem J. ;
Bertrand, Michel ;
Fox, Kim .
HEART, 2007, 93 (09) :1081-1086
[7]   Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure [J].
Bristow, MR ;
Saxon, LA ;
Boehmer, J ;
Krueger, S ;
Kass, DA ;
De Marco, T ;
Carson, P ;
DiCarlo, L ;
DeMets, D ;
White, BG ;
DeVries, DW ;
Feldman, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2140-2150
[8]   Early and Long-term Outcomes of Heart Failure in Elderly Persons, 2001-2005 [J].
Curtis, Lesley H. ;
Greiner, Melissa A. ;
Hammill, Bradley G. ;
Kramer, Judith M. ;
Whellan, David J. ;
Schulman, Kevin A. ;
Hernandez, Adrian F. .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (22) :2481-2488
[9]  
Fox KM, 2003, LANCET, V362, P782
[10]   Economic evaluation of the randomized aldactone evaluation study (RALES): Treatment of patients with severe heart failure [J].
Glick, HA ;
Orzol, SM ;
Tooley, JF ;
Remme, WJ ;
Sasayama, S ;
Pitt, B .
CARDIOVASCULAR DRUGS AND THERAPY, 2002, 16 (01) :53-59